A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)
Clinical trial NCT03136770 · COMPLETED
Trial details
- NCT number
- NCT03136770
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2017-04-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.